All articles from EyeWorld.org on the topic of cataract surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.

EyeWorld Weekly, June 30, 2023

➤ Study evaluates safety of office-based lens surgery ➤ FDA issues response to BLA for 8 mg aflibercept ➤ Pre-clinical data for non-viral gene therapy ➤ Non-human primate study of dry AMD therapy ➤ Expanded insurance coverage for MIGS procedures ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, June 30, 2023

TOPGUN: Phaco Mavericks

The purpose of “TOPGUN: Phaco Mavericks,” said David Chang, MD, is to have the world’s top phaco instructors provide their best pearls in cataract surgery. The symposium, which took place at the 2023 ASCRS Annual Meeting, included two teams—ASCRS members and an international team with members from ESCRS, APACRS, and LASCRS.

Comments Off on TOPGUN: Phaco Mavericks

Study evaluates patient perceptions of immediately sequential and delayed cataract surgery

Immediately sequential bilateral cataract surgery (ISBCS) has been gaining steam, both in discussion and in practice, but as the authors of a recent Journal of Cataract & Refractive Surgery paper point out, it “remains a subject of controversy in ophthalmology.”

Comments Off on Study evaluates patient perceptions of immediately sequential and delayed cataract surgery

EyeWorld Weekly, May 19, 2023

➤ Researchers discover new class of drugs that could treat retinal dystrophies ➤ Enrollment complete in Phase 1/2a study using novel dry eye treatment approach ➤ NDA submitted to FDA for investigational inflammation and pain treatment ➤ Study: first-in-human gene therapy trial for achromatopsia ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, May 19, 2023

EyeWorld Weekly, May 12, 2023

➤ FDA approves ophthalmic spray for mydriasis ➤ FDA accepts NDA for travoprost intraocular implant ➤ FDA accepts supplemental BLA for treatment for macular edema ➤ FDA 510(k) clearance granted to green pattern laser photocoagulator ➤ NDA submitted for pain and inflammation nanoemulsion ➤ Positive clinical results from IOP-monitoring contact lens ➤ Study provides real-world data comparing MIGS using IRIS Registry ➤ FDA approves IOL positioning system ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, May 12, 2023

EyeWorld Weekly, May 5, 2023

➤ Topline data from Phase 3 presbyopia drop trial ➤ Femtosecond laser for LASIK receives FDA clearance ➤ Enrollment complete for hydrophobic trifocal IOL trial ➤ Early results from clinical trial for dry eye therapy ➤ FDA clears IND application for clinical trial of therapy for X-linked retinoschisis ➤ Innovations in capsulotomy creation device ➤ Company acquisition news ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, May 5, 2023

EyeWorld Weekly, April 28, 2023

➤ FDA approves new monofocal IOL ➤ Topline Phase 3 results for fixed-dose combination presbyopia drop ➤ Gene therapy trial produces positive Phase 1/2 data for Leber congenital amaurosis ➤ New data shows investigational compound protects endothelium for cataract patients undergoing Fuchs treatment ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, April 28, 2023

EyeWorld Journal Club review: “Visual recovery after immediate sequential bilateral cataract surgery at a veterans’ hospital” 

The New York University Langone Health ophthalmology residents review this article from the November 2022 issue of the Journal of Cataract & Refractive Surgery.

Comments Off on EyeWorld Journal Club review: “Visual recovery after immediate sequential bilateral cataract surgery at a veterans’ hospital” 

EyeWorld Weekly, April 21, 2023

➤ First in-human, non-invasive femtosecond laser trabeculotomy data ➤ Special Protocol Assessment received for Phase 2b/3 trial for dry AMD treatment ➤ FDA gives clearance to IND for geographic atrophy treatment ➤ Positive preliminary data in trial for retinitis pigmentosa and Leber congenital amaurosis therapy ➤ Wet AMD treatment proceeds to Phase 2 trial ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, April 21, 2023